Shares of 3D Systems (DDD) - Get Report and CollPlant Biotechnologies (CLGN) - Get Report advanced after the companies unveiled an agreement to develop breast-reconstruction treatments.
The companies said they would produce bioprinted regenerative soft tissue matrix to be combined with implants in breast-reconstruction procedures.
In January 3D Systems, the Rock Hill, S.C., 3D-printing company, said it would increase investment in regenerative medicine, Jeffrey Graves, president and chief executive of 3D Systems, said in a statement.
CollPlant is the Rehovot, Israel, biotech focused on tissue repair.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.